denkapparat Operations’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,856
Closed -$316K 402
2026
Q1
$316K Hold
21,856
0.13% 268
2025
Q4
$311K Hold
21,856
0.17% 233
2025
Q3
$172K Hold
21,856
0.11% 272
2025
Q2
$125K Hold
21,856
0.1% 240
2025
Q1
$178K Buy
21,856
+3,652
+20% +$33.8K 0.19% 209
2024
Q4
$171K Buy
+18,204
New +$189K 0.25% 162

Other funds holding FOLD

denkapparat Operations's FOLD Position: Q2 2026 in Review

denkapparat Operations sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 21,856 shares — an estimated $316K sold.

denkapparat Operations first reported a position in FOLD in Q4 2024 and held it in 6 quarters. The position peaked at $316K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • denkapparat Operations reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • denkapparat Operations sold 21,856 Amicus Therapeutics shares in Q2 2026, an estimated $316K.
  • denkapparat Operations first reported a position in Amicus Therapeutics in Q4 2024 and held it in 6 quarters.
  • denkapparat Operations's Amicus Therapeutics position peaked at $316K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.